Sotalol New Zealand - English - Medsafe (Medicines Safety Authority)

sotalol

viatris limited - sotalol hydrochloride 160mg - tablet - 160 mg - active: sotalol hydrochloride 160mg excipient: calcium hydrogen phosphate magnesium stearate maize starch povidone purified talc sodium starch glycolate - sotalol hydrochloride is indicated for use in the prevention and treatment of supraventricular and ventricular arrhythmias.

Sotalol New Zealand - English - Medsafe (Medicines Safety Authority)

sotalol

viatris limited - sotalol hydrochloride 80mg - tablet - 80 mg - active: sotalol hydrochloride 80mg excipient: calcium hydrogen phosphate magnesium stearate maize starch povidone purified talc sodium starch glycolate - sotalol hydrochloride is indicated for use in the prevention and treatment of supraventricular and ventricular arrhythmias.

Amizide tablet Australia - English - Department of Health (Therapeutic Goods Administration)

amizide tablet

alphapharm pty ltd - hydrochlorothiazide, quantity: 50 mg; amiloride hydrochloride dihydrate, quantity: 5 mg - tablet, uncoated - excipient ingredients: sodium starch glycollate; lactose monohydrate; magnesium stearate; povidone; wheat starch - amizide is indicated in the treatment of patients with: oedema of cardiac origin; hepatic cirrhosis with ascites; hypertension in whom potassium depletion might be anticipated. amizide, with its combination of amiloride hydrochloride and hydrochlorothiazide, minimizes the possibility of the development of excessive potassium loss in patients during vigorous diuresis for prolonged periods. amizide, with it's built in potassium sparing agent, is especially indicated in those conditions where the positive effect on potassium balance is particularly important. hypertension. amizide may be used alone or as an adjunct to other anti-hypertensive drugs. since it enhances the action of these agents, the dosage of these antihypertensive drugs may need to be reduced to avoid the risk of an excessive drop in blood pressure.

MIDAZOLAM HYDROCHLORIDE- midazolam hydrochloride injection, solution United States - English - NLM (National Library of Medicine)

midazolam hydrochloride- midazolam hydrochloride injection, solution

hospira, inc. - midazolam hydrochloride (unii: w7ttw573jj) (midazolam - unii:r60l0sm5bc) - midazolam 1 mg in 1 ml - midazolam injection is indicated: - intramuscularly or intravenously for preoperative sedation/anxiolysis/amnesia; - intravenously as an agent for sedation/anxiolysis/amnesia prior to or during diagnostic, therapeutic or endoscopic procedures, such as bronchoscopy, gastroscopy, cystoscopy, coronary angiography, cardiac catheterization, oncology procedures, radiologic procedures, suture of lacerations and other procedures either alone or in combination with other cns depressants; - intravenously for induction of general anesthesia, before administration of other anesthetic agents. with the use of narcotic premedication, induction of anesthesia can be attained within a relatively narrow dose range and in a short period of time. intravenous midazolam can also be used as a component of intravenous supplementation of nitrous oxide and oxygen (balanced anesthesia); - continuous intravenous infusion for sedation of intubated and mechanically ventilated patients as a component of anesthesia or during treatment in a c

Plasma-Lyte 148 & Glucose 5% infusion 500ml Viaflo bags United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

plasma-lyte 148 & glucose 5% infusion 500ml viaflo bags

baxter healthcare ltd - sodium gluconate; sodium acetate trihydrate; magnesium chloride hexahydrate; potassium chloride; sodium chloride; glucose monohydrate - infusion - 5.02gram/1litre ; 3.68gram/1litre ; 300mg/1litre ; 370mg/1litre ; 5.26gram/1litre ; 55gram/1litre

Wright Medical Orthopaedic Plating System - Internal orthopaedic fixation system, plate/screw, non-bioabsorbable, non-sterile Australia - English - Department of Health (Therapeutic Goods Administration)

wright medical orthopaedic plating system - internal orthopaedic fixation system, plate/screw, non-bioabsorbable, non-sterile

stryker australia pty ltd - 61689 - internal orthopaedic fixation system, plate/screw, non-bioabsorbable, non-sterile - intended for use in stabilization of fresh fractures, revision procedures, joint fusion and reconstruction of small bones of the hand, feet, wrist, ankles, fingers, and toes.

Upright New Zealand - English - Ministry for Primary Industries

upright

nufarm limited - chlorethephon; mepiquat-chloride - chlorethephon 155 g/litre; mepiquat-chloride 305 g/litre - plant growth regulator

BRIGHTER DAYS Australia - English - Department of Health (Therapeutic Goods Administration)

brighter days

mecca brands pty ltd - excipient ingredients: - did you know pairing your daily spf with a vitamin c serum offers extra skincare benefit? that?s why these two products are the perfect match. apply our skin brightening vitamin c serum first: it?s rich in antioxidants, revitilising and never sticky - plus its blend of 15% l-ascorbic acid, ferulic acid and vitamin e leaves the skin refreshed, glowing and may aid in diminishing the appearance of ageing. apply the to save face spf50+ superscreen oxybenzone free formula over the top; it provides broad spectrum protection against uva and uvb rays with a hydrating matte finish that sits perfectly under makeup.

Meo Healthcare Organic Zinc Australia - English - Department of Health (Therapeutic Goods Administration)

meo healthcare organic zinc

mega lifesciences (australia) pty ltd - magnesium amino acid chelate,manganese amino acid chelate,pyridoxine hydrochloride,zinc amino acid chelate -